38
Participants
Start Date
September 30, 2006
Primary Completion Date
August 31, 2008
Study Completion Date
December 31, 2009
sorafenib (200 or 400mg bid) and taxotere iv
200 mg BID, day 3-19 cycle 1, day 2-19 other cycles 200 mg BID, day 3-21 Cycle 1, day 1-21 other cycles 400 mg BID, day 3-19 cycle 1, day 2-19 other cycles 400 mg BID, day 3-21 cycle 1, day 1-21 other cycles
Cliniques Universitaires St Luc, Brussels
St Pierre, Ottignies
Sainte Elisabeth, Namur
Clinique Universiataire de Mont Godinne, Yvoir
Notre Dame et Reine Fabiola, Charleroi
Hôpital Européen Georges Pompidou, Paris
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER